← Back to Search

Other

Blood Flow Restriction Training for Vascular Health

N/A
Waitlist Available
Led By Hirofumi Tanaka, PhD
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline measurement and measurement at 2 weeks
Awards & highlights

Study Summary

This trialinvestigates how different types of Blood Flow Restriction (BFR) resistance training affects vascular health, and if one type improves vascular health better than the other. Both types are equally effective at increasing muscle strength.

Who is the study for?
This trial is for healthy, sedentary or recreationally active young adults aged 18-40 who have agreed to participate. It's not suitable for those on cardiovascular medications, with morbid obesity, current smokers, people with hypertension or overt cardiovascular disease, anyone currently doing resistance training, or those diagnosed with COVID-19.Check my eligibility
What is being tested?
The study is examining how blood flow restriction (BFR) resistance training affects vascular function in participants. Two types of BFR devices are being compared: wide-rigid cuffs and narrow elastic bands. The hypothesis suggests that while both may increase muscle strength, the effects on vascular health could differ.See study design
What are the potential side effects?
Potential side effects might include minor and reversible impacts on vascular function from using wide-rigid cuffs for BFR training. Narrow elastic bands may improve vascular function but specific side effect profiles are not detailed.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline measurement and measurement at 2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline measurement and measurement at 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline grip strength at 2 weeks
Change from baseline muscle strength at 2 weeks
Change from baseline vascular function at 2 weeks
Secondary outcome measures
Blood flow responses to different types of cuff
Change from baseline arterial stiffness at 2 weeks
Change from baseline blood lactate concentration
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Wide-rigid cuffExperimental Treatment1 Intervention
The wide-rigid cuff will be randomly assigned to one of the subject's arms.
Group II: Narrow-elastic bandExperimental Treatment1 Intervention
The narrow-elastic band will be randomly assigned to another arm of the subject.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Blood flow restriction resistance training
2020
N/A
~30

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
356 Previous Clinical Trials
81,454 Total Patients Enrolled
Hirofumi Tanaka, PhDPrincipal InvestigatorThe University of Texas at Austin
3 Previous Clinical Trials
109 Total Patients Enrolled

Media Library

Blood flow restriction resistance training (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05451641 — N/A
Flow-mediated Dilatation Research Study Groups: Wide-rigid cuff, Narrow-elastic band
Flow-mediated Dilatation Clinical Trial 2023: Blood flow restriction resistance training Highlights & Side Effects. Trial Name: NCT05451641 — N/A
Blood flow restriction resistance training (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05451641 — N/A
~0 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top